Neonatal mesenchymal-like cells adapt to surrounding cells

Stem Cell Research

Volumn 11, Issue 1, 2013, Pages 634-646

  Liedtke, Stefanie ^a   Freytag, Eva Maria ^a   Bosch, Julia ^a   Houben, Amelie Pia ^a   Radke, Teja Falk ^a   Deenen, René ^b   Köhrer, Karl ^b   Kögler, Gesine ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; FETAL BLOOD; GENE EXPRESSION; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MESENCHYMAL STROMAL CELLS; TRANSFECTION;

EID: 84877329670     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.04.001     Document Type: Article

References (39)

1. Abdallah B.M., Kassem M. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J. Cell. Physiol. 2009, 218:9-12.
2. Adams S.L., Cohen A.J., Lassova L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J. Cell. Physiol. 2007, 213:635-641.
3. Ahrens M., Ankenbauer T., Schroder D., Hollnagel A., Mayer H., Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 1993, 12:871-880.
4. Bakin A.V., Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999, 283:387-390.
5. Bianco P. Back to the future: moving beyond "mesenchymal stem cells". J. Cell. Biochem. 2011, 112:1713-1721.
6. Bianco P. Minireview: the stem cell next door: skeletal and hematopoietic stem cell "niches" in bone. Endocrinology 2011, 152:2957-2962.
7. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
8. Bosch J., Houben A.P., Radke T.F., Stapelkamp D., Bunemann E., Balan P., Buchheiser A., Liedtke S., Kogler G. Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?. Stem Cells Dev. 2012, 21:1977-1988.
9. Chamberlain J.R., Schwarze U., Wang P.R., Hirata R.K., Hankenson K.D., Pace J.M., Underwood R.A., Song K.M., Sussman M., Byers P.H., Russell D.W. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004, 303:1198-1201.
10. Creuzet S., Couly G., Vincent C., Le Douarin N.M. Negative effect of Hox gene expression on the development of the neural crest-derived facial skeleton. Development 2002, 129:4301-4313.
11. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4:3.
12. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
13. Erices A., Conget P., Rojas C., Minguell J.J. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp. Cell Res. 2002, 280:24-32.
14. Fraser J.K., Wulur I., Alfonso Z., Hedrick M.H. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006, 24:150-154.
15. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. J. Cell. Biochem. 2006, 97:33-44.
16. Griffiths M.J., Bonnet D., Janes S.M. Stem cells of the alveolar epithelium. Lancet 2005, 366:249-260.
17. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994, 266:443-448.
18. Grigoriadis A.E., Wang Z.Q., Wagner E.F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 1995, 11:436-441.
19. Gruss P., Kessel M. Axial specification in higher vertebrates. Curr. Opin. Genet. Dev. 1991, 1:204-210.
20. Hansen S.L., Myers C.A., Charboneau A., Young D.M., Boudreau N. HoxD3 accelerates wound healing in diabetic mice. Am. J. Pathol. 2003, 163:2421-2431.
21. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
22. Ichida F., Nishimura R., Hata K., Matsubara T., Ikeda F., Hisada K., Yatani H., Cao X., Komori T., Yamaguchi A., Yoneda T. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 2004, 279:34015-34022.
23. Jeltsch K.S., Radke T.F., Laufs S., Giordano F.A., Allgayer H., Wenz F., Zeller W.J., Kogler G., Fruehauf S., Maier P. Unrestricted somatic stem cells: interaction with CD34+ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential. Cytotherapy 2011, 13:357-365.
24. Kluth S.M., Buchheiser A., Houben A.P., Geyh S., Krenz T., Radke T.F., Wiek C., Hanenberg H., Reinecke P., Wernet P., Kogler G. DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev. 2010, 19:1471-1483.
25. Kmita M., Duboule D. Organizing axes in time and space; 25years of colinear tinkering. Science 2003, 301:331-333.
26. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., Liedtke S., Sorg R.V., Fischer J., Rosenbaum C., Greschat S., Knipper A., Bender J., Degistirici O., Gao J., Caplan A.I., Colletti E.J., Almeida-Porada G., Muller H.W., Zanjani E., Wernet P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004, 200:123-135.
27. Kogler G., Radke T.F., Lefort A., Sensken S., Fischer J., Sorg R.V., Wernet P. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp. Hematol. 2005, 33:573-583.
28. Kogler G., Critser P., Trapp T., Yoder M. Future of cord blood for non-oncology uses. Bone Marrow Transplant. 2009, 44:683-697.
29. Krosl J., Sauvageau G. AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 2000, 19:5134-5141.
30. Krumlauf R. Hox genes in vertebrate development. Cell 1994, 78:191-201.
31. Leucht P., Kim J.B., Amasha R., James A.W., Girod S., Helms J.A. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 2008, 135:2845-2854.
32. Liedtke S., Buchheiser A., Bosch J., Bosse F., Kruse F., Zhao X., Santourlidis S., Kogler G. The HOX Code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res. 2010, 5:40-50.
33. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
34. Lohberger B., Payer M., Rinner B., Kaltenegger H., Wolf E., Schallmoser K., Strunk D., Rohde E., Berghold A., Pekovits K., Wildburger A., Leithner A., Windhager R., Jakse N. Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells. J. Craniomaxillofac. Surg. 2012, 41:110-118.
35. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2012, 13:27-38.
36. Sherman B.T., Huang da W., Tan Q., Guo Y., Bour S., Liu D., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinforma. 2007, 8:426.
37. Song L., Liu M., Ono N., Bringhurst F.R., Kronenberg H.M., Guo J. Loss of wnt/beta-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes. J. Bone Miner. Res. 2012, 27:2344-2358.
38. Takada I., Kouzmenko A.P., Kato S. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opin. Ther. Targets 2009, 13:593-603.
39. Trigueros Motos L., Gonzalez Granado J.M., Cheung C., Fernandez P., Sanchez Cabo F., Dopazo A., Sinha S., Andres V. Embryological-origin-dependent differences in Hox expression in adult aorta: role in regional phenotypic variability and regulation of NF-κB activity. Arterioscler. Thromb. Vasc. Biol. 2013, 33. (Epub ahead of print).